General Information
DRAVP ID DRAVPe01761
Peptide Name MBD-4 (11-40)(P9)
Sequence NGAICWGPCPTAFRQIGNCGHFKVRCCKIR
Sequence Length 30
UniProt ID P82019
Source Synthetic construct
Activity Information
Target Organism SARS-CoV-2
Assay Plaque reduction assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target Not found
Mechanism Mechanistic studies show that positively charged P9 broadly inhibits viral replication by binding to different viruses and then inhibits virus–host endosomal acidification to prevent the endosomal release of pH-dependent viruses.
Structure Information
PDB ID 6M56
Predicted Structure Download No predicted structure available
Linear/Cyclic Linear
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C144H227N47O35S5
Absent amino acids DELMSY
Common amino acids C
Mass 3336.98
Pl 9.41
Basic residues 6
Acidic residues 0
Hydrophobic residues 9
Net charge 6
Boman Index -4104
Hydrophobicity -6.67
Aliphatic Index 55.33
Half Life
Extinction Coefficient cystines 5750
Absorbance 280nm 198.28
Polar residues 12
Literature Information
Literature 1
Title A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses.
Pubmed ID 26911565
Reference Sci Rep. 2016 Feb 25;6:22008.
Author Zhao H, Zhou J, Zhang K, Chu H, Liu D, Poon VK, Chan CC, Leung HC, Fai N, Lin YP, Zhang AJ, Jin DY, Yuen KY, Zheng BJ.
Literature 2
Title A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2.
Pubmed ID 32843628
Reference Nat Commun. 2020 Aug 25;11(1):4252.
Author Zhao H, To KKW, Sze KH, Yung TT, Bian M, Lam H, Yeung ML, Li C, Chu H, Yuen KY.